The Peril of €300 Million for Biomedicine in Berlin

January 27, 2013  •  From theTrumpet.com
Germany goes full circle from IG Farben to Bayer, BASF, Hoechst and Cassella.

Germany has combined its largest biomedical research and development facilities into one super company that is set to gain at minimum €300 million within the next five years. The Berlin Institute of Health (bhi) is now an undisputed leader of European medicine. This past November, key decision makers were on hand in Dusseldorf to spread this announcement at the world’s largest medical trade fair, medica.

The goal of bhi is to court the world’s top-flight scientific and medical minds and use its influential role with federal and state governments, along with university and private research and development.

The rest of this article is available to Trumpet online account holders. Signing up is quick and free of charge with no obligation. To get started, please click the button below.

Literature Offer

For further study into this subject, read Who or What Is the Prophetic Beast? along with Germany and the Holy Roman Empire.